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NA is the essence of biological diversity. But
it’s responsible for more than just the basics
like eye color, hair texture or height. At a less
visible level, DNA also varies our bodies’ reactions
to our environment. It’s also the foundation of
personalized medicine, a developing medical model
that takes our genetic differences into account.
This new approach may reshape the future of
diagnostics.
But to get there, environmental effects on DNA
need to be understood. That’s where Douglas
Ruden, Ph.D., associate professor and director of
epigenomics at WSU’s Institute of Environmental
Health Sciences, comes in.
As part of his extensive research on lead
exposure’s genetic effects, Ruden is searching for
genetic signatures of lead sensitivity to refine
prevention and treatment of lead poisoning, which
according to the City of Detroit has affected 58
percent of Detroit Public Schools’ students.
Genomes are complex blueprints of our biological
identities that comprise the complete sequence
of our genes. Genes are stretches of DNA, and
DNA is composed of billions of chemical bases
named either A, T, G or C. But each person’s
four-letter sequence is patterned differently, with
different arrangements accounting for different
traits. If the manifestations of these arrangements
are understood, then physicians can use this
information to customize prevention and treatment
for patients.
“That’s sort of the fantasy,” said Ruden. “We
could be two years away from that or it could be 20
years. But that’s the goal.”
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To help reach that goal, Ruden examined the
genomes of both lead-exposed and healthy fruit
flies – the same species that led Thomas Hunt
Morgan to formulate the theory of heredity nearly
a century ago. Ruden measured the flies’ genetic
traits, “but instead of something quantitative like
height, we measured the expression of all 20,000
genes,” he said.
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“Once lead binds to these
transcriptional regulators…
it activates several hundred
genes.”

several hundred genes,” said Ruden. “And those
genes that are activated or suppressed tend to be
in neural developmental processes, like synapse
formation.” In fact, lead poisoning manifests
itself primarily in the central nervous system and
can cause learning problems, memory loss and
poor coordination – in addition to a host of other
symptoms throughout the body.
Now, Ruden is targeting the location of these
pathways to identify the transcriptional regulators
with which lead co-regulates the production of
many of the body’s molecular elements. And
finding those regulators will expand the scientific
understanding of genetic and bioenvironmental
interactions while bringing the world closer to a day
when medical diagnostics is as particular as
our DNA.

— Dr. Douglas Ruden, Ph.D.
About Dr. Douglas Ruden:
What Ruden has found thus far are nearly a
dozen genetic pathways that are co-regulated by
lead. Each of these genetic pathways is the sum of
interactions among genes that produce the lead
sensitivity trait. But when lead co-regulates this
process, it is partially controlling how and at what
rate proteins are being developed, activating some
genes and turning others off.
“Once lead binds to these transcriptional
regulators [that dictate gene expression], it activates
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Dr. Ruden received B.S. degrees in biology and chemistry
from the California Institute of Technology and a Ph.D.
in biochemistry from Harvard University. He was a
postdoctoral fellow at the Max Planck Institute. He joined
Wayne State University in 2004.
For more information, visit:
http://www.iehs.wayne.edu/bio.php?id=44317
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